Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apokyn for Delayed Onset of L-Dopa Action in PD
NCT01770145Phase 4Completed
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Start
- Dec 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apomorphine in Parkinson's disease (PD), sponsored by Supernus Pharmaceuticals, Inc.. Started Dec 2012; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01770145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01770145.